Daniel V Ebner

14PUBLICATIONS
73CO-AUTHORS
PharmacogenomicsMedical molecular engineering of nucleic acids and proteinsWater treatment processesMolecular targetsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 20, 2026
The changing face of UK academic drug screening in the past decade.

|Nov 27, 2023
Author Correction: C16orf72/HAPSTR1/TAPR1 functions with BRCA1/Senataxin to modulate replication-associated R-loops and confer resistance to PARP disruption.

Abhishek Bharadwaj Sharma, Muhammad Khairul Ramlee, Joel Kosmin

|Oct 14, 2023
Selective ROCK Inhibitor Enhances Blood Flow Recovery after Hindlimb Ischemia.

Hend Salah Fayed, Mouayad Zuheir Bakleh, Jasni Viralippurath Ashraf

|Aug 17, 2023
C16orf72/HAPSTR1/TAPR1 functions with BRCA1/Senataxin to modulate replication-associated R-loops and confer resistance to PARP disruption.

Abhishek Bharadwaj Sharma, Muhammad Khairul Ramlee, Joel Kosmin

|Jan 23, 2023
Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models.

Gonzalo Rodriguez-Berriguete, Marco Ranzani, Remko Prevo

|Nov 13, 2021
CHK1 inhibition exacerbates replication stress induced by IGF blockade.

Xiaoning Wu, Elena Seraia, Stephanie B Hatch

Pageof 3

Frequent Collaborators

2 joint publications

George E Ronson

2 joint publications

Stephanie B Hatch

2 joint publications

Ian Gibbs-Seymour

2 joint publications

Martin R Higgs